Xiangnan Dang

Company: Eli Lilly & Co.

Job title: Director - Engineering

Seminars:

Panel Discussion: Establishing Novel Anchors for Validating Digital Biomarkers in Neurological Indications 12:00 pm

How can digital biomarkers be validated in neurological indications with poor anchors? What are the regulatory requirements for digital biomarker validation? Debating the potential of digital biomarkers as primary endpoints, co-endpoints, or secondary endpointsRead more

day: Conference Day One